Event-Driven Stocks

Vireo Growth Inc.

VREOFOTC

Healthcare · Pharmaceutical Preparations · A1 · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 2 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$268.8M$99.4M$88.1M$74.6M$54.4M$49.2M
Operating income−$1.0M$13.6M$10.6M−$6.9M−$20.5M−$23.0M
Net income−$68.1M−$28.0M−$25.5M−$42.5M−$33.7M−$22.9M
Total assets$817.2M$278.9M$183.3M$159.2M$167.0M$102.6M
Total liabilities$509.7M$223.3M$199.3M$155.7M$124.0M$40.3M
Equity$307.4M$55.6M−$16.0M$3.4M$43.0M$62.3M
EPS (diluted)$-0.09$-0.16$-0.19$-0.33$-0.27$-0.24
Shares out.734.7M180.4M135.2M128.1M123.8M97.6M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−0.4%
Net margin
−25.3%
Return on equity
−22.2%
Return on assets
−8.3%
Return on capital (ROCE)
−0.2%
Liabilities / assets
62.4%
Debt / equity
1.66×
Book value / share
$0.42
Revenue growth (YoY)
170.4%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
0.34distress
Accruals / assets
−8.8%clean
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
63
/ 100
Profitability 0Growth 100Catalyst 67Earnings quality 100Financial strength 50

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 1 severe● 2 warning● 3 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue is growing year-over-year
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202642,4711.0-75.7%
Apr 30, 2026174,8971.0+260.3%
Apr 15, 202648,5471.0-47.8%
Mar 31, 202692,9661.0+11.7%
Mar 13, 202683,2021.0-20.0%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.